Weill Cornell Medicine
For over a decade, Amy has been interested in understanding how the human brain works in order to better diagnose, prognose and treat neurological disease and injury. Quantitative approaches, including machine learning, applied to data from rapidly evolving neuroimaging techniques, have the potential to enable ground-breaking discoveries about how the brain works. Amy has particular interest in non-invasive brain stimulation and pharmacological interventions, like psychedelics, that may be used to modulate brain activity and promote recovery from disease or injury. Amy is also the founder and co-director of the cross-campus working group Machine Learning in Medicine, which aims to bring together ML researchers in Cornell-Ithaca/Cornell-Tech and clinicians and researchers at WCM to address medicine's toughest problems.